Fluorescence spectroscopy for the detection of potentially malignant disorders and squamous cell carcinoma of the oral cavity by Francisco, Ana Lucia Noronha et al.
  Universidade de São Paulo
 
2014-06
 
Fluorescence spectroscopy for the detection of
potentially malignant disorders and squamous
cell carcinoma of the oral cavity
 
 
Photodiagnosis and Photodynamic Therapy, Amsterdam : Elsevier BV, v. 11, n. 2, p. 82-90, June
2014
http://www.producao.usp.br/handle/BDPI/50794
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Física e Ciências Materiais - IFSC/FCM Artigos e Materiais de Revistas Científicas - IFSC/FCM
Photodiagnosis and Photodynamic Therapy (2014) 11, 82—90
Available  online  at  www.sciencedirect.com
ScienceDirect
jo ur nal ho mepage: www.elsev ier .com/ locate /pdpdt
Fluorescence  spectroscopy  for  the
detection of  potentially  malignant  disorders
and squamous  cell  carcinoma
of the  oral  cavity
Ana  Lucia  Noronha  Francisco  PhDa,  Wagner  Rafael  Correrb,
Luciane  Hiramatsu  Azevedo  PhDc,  Vivian  Galletta  Kern  PhDc,
Clóvis Antônio  Lopes  Pinto  PhDd,  Luiz  Paulo  Kowalski  PhDe,∗,
Cristina  Kurachi  PhDb,∗∗
a Department  of  Oral  Diagnosis,  School  of  Dentistry  of  Piracicaba,  University  of  Campinas  (UNICAMP),  Av.
Limeira  901,  Piracicaba  13414-018,  São  Paulo,  Brazil
b Department  of  Physics  and  Materials  Science,  Physics  Institute  of  São  Carlos,  University  of  São  Paulo
(USP),  Av.  Trabalhador  São-Carlense  400,  São  Carlos  13566-590,  São  Paulo,  Brazil
c Special  Laboratory  of  Laser  in  Dentistry,  School  of  Dentistry  of  São  Paulo,  University  of  São  Paulo  (USP),
Av. Professor  Lineu  Prestes,  Cidade  Universitária,  São  Paulo  05508-000,  São  Paulo,  Brazil
d Department  of  Pathology,  A.C.  Camargo  Cancer  Center,  Rua  Prof.  Antonio  Prudente  211,  São  Paulo
01509-900,  São  Paulo,  Brazil
e Department  of  Head  and  Neck  Surgery  and  Otorhinolaryngology,  A.C.  Camargo  Cancer  Center  and  the
National Institute  of  Science  and  Technology  in  Oncogenomics  (INCITO),  Rua  Prof.  Antonio  Prudente  211,
São Paulo  01509-900,  São  Paulo,  Brazil
Available  online  4  April  2014
KEYWORDS
Squamous  cell
carcinoma;
Fluorescence
spectroscopy;
Early  diagnosis;
Potentially  malignant
disorders;
Oral cavity
Summary  Oral  cancer  is  a  public  health  problem  with  relevant  incidence  in  the  world  pop-
ulation.  The  affected  patient  usually  presents  advanced  stage  disease  and  the  consequence
of  this  delay  is  a  reduction  in  survival  rates.  Given  this,  it  is  essential  to  detect  oral  cancer
at early  stages.  Fluorescence  spectroscopy  is  a  non-invasive  diagnostic  tool  that  can  improve
cancer  detection  in  real  time.  It  is  a  fast  and  accurate  technique,  relatively  simple,  which
evaluates  the  biochemical  composition  and  structure  using  the  tissue  ﬂuorescence  spectrum
as  interrogation  data.  Several  studies  have  positive  data  regarding  the  tools  for  differentiat-
ing  between  normal  mucosa  and  cancer,  but  the  difference  between  cancer  and  potentially
malignant disorders  is  not  clear.
The  aim  of  this  study  was  to  evaluate  the  efﬁcacy  of  ﬂuorescence  spectroscopy  in  the  dis-
crimination  of  normal  oral  mucosa,  oral  cancer,  and  potentially  malignant  disorders.
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The  ﬂuorescence  spectroscopy  was  evaluated  in  115  individuals,  of  whom  55  patients  presented
oral squamous  cell  carcinoma,  30  volunteers  showing  normal  oral  mucosa,  and  30  patients  having
potentially  malignant  disorders.  The  spectra  were  classiﬁed  and  compared  to  histopathology  to
evaluate  the  efﬁciency  in  diagnostic  discrimination  employing  ﬂuorescence.  In  order  to  classify
the spectra,  a  decision  tree  algorithm  (C4.5)  was  applied.  Despite  of  the  high  variance  observed
in spectral  data,  the  speciﬁcity  and  sensitivity  obtained  were  93.8%  and  88.5%,  respectively  at
406 nm  excitation.  These  results  point  to  the  potential  use  of  ﬂuorescence  spectroscopy  as  an
important  tool  for  oral  cancer  diagnosis  and  potentially  malignant  disorders.
© 2014  Elsevier  B.V.  All  rights  reserved.
Introduction
Annually,  about  10  million  malignant  tumors  are  diagnosed
worldwide,  and  cancer  of  the  oral  cavity  represents  6%  of
all  cases  [1,2].  Different  tumors  may  affect  the  oral  cav-
ity,  and  oral  squamous  cell  carcinoma  (OSCC)  is  the  most
frequent  one,  representing  90%  of  all  cases  [2—5].  Unfor-
tunately,  in  most  cases,  the  patients  present  for  treatment
with  advanced  stage  disease,  with  consequent  decrease  in
survival  rates  [1,6].  The  treatment  of  these  patients  is  usu-
ally  aggressive  and  may  be  mutilating  [7].  Despite  the  recent
advances  in  the  treatment  of  OSCC,  there  has  been  only  a
small  increase  in  the  survival  rate  [8].
Disease  local  and  regional  control  and  rehabilitation  of
patients  with  advanced  oral  carcinoma  are  extremely  dif-
ﬁcult.  On  the  other  hand,  initial  lesions  are  more  easily
removed  with  less  patient  mutilation  and  better  prognosis
[9,10].
Some  OSCC  lesions  come  from  pre-existing  potentially
malignant  disorders  [6,11]  with  the  annual  malignant  trans-
formation  rate  of  approximately  1%  [11,12]. Patients  with
previous  history  of  oral  cancer,  especially  those  that  had
been  heavy  smokers,  present  an  altered  oral  mucosa  (can-
cerization  ﬁeld).  Although  oral  lesions  are  common,  to
predict  the  biological  behavior  of  them  remains  a  chal-
lenge.  The  standard  methodology  for  the  diagnosis  of
these  lesions  is  clinical  examination  and  histopatholog-
ical  analysis.  Most  oral  potentially  malignant  disorders
(PMD)  are  clinically  present  as  leukoplakia  or  erythro-
plakia,  but  histologically  they  can  show  a  wide  variety
of  phenotypes,  such  as  hyperkeratosis,  dysplasia  or  even
carcinoma  [13].
Currently,  there  is  great  interest  in  optical  techniques
that  use  ﬂuorescence  to  evaluate  lesions  using  a  non-
invasive  procedure.  Based  on  the  tissue  optical  properties
and  diagnostic  sensitivity  to  capture  the  ﬂuorescence  emit-
ted  by  native  ﬂuorophores,  these  optical  techniques  have
been  indicated  to  differentiate  endogenous  tissue  varia-
tions  [14—16].  The  ﬂuorescence  spectroscopy  has  become  an
important  tool  in  detecting  potentially  malignant  and  malig-
nant  lesions  in  the  oral  mucosa  [17,18].  The  biochemical
composition  and  tissue  architecture  can  be  assessed  by  the
emitted  ﬂuorescence  spectrum,  which  will  be  modiﬁed  in
the  presence  of  tissue  alterations  [19].  Mathematical  algo-
rithms  can  then  be  developed  and  optimized  to  classify  the
respective  tissues  in  histological  categories  based  on  their
spectral  characteristics  [20—23].
The  aim  of  this  study  was  to  determine  the  ability  of  ﬂuo-
rescence  spectroscopy  to  discriminate  normal  and  abnormal
oral  mucosa,  potentially  malignant  and/or  malignant  oral
lesions.
Patients and methods
This  prospective  study  was  performed  at  the  Department
of  Head  and  Neck  Surgery  and  Otorhinolaryngology,  A.C.
Camargo  Cancer  Center  and  LELO-USP  (Special  Laboratory  of
Laser  Dentistry),  São  Paulo,  Brazil.  The  clinical  research  pro-
tocol  was  approved  by  the  Ethical  Committee  of  the  partic-
ipant  institutions,  and  all  recruited  patients  that  agreed  to
participate  as  volunteers  signed  an  informed  consent  form.
The  ﬂuorescence  spectroscopy  system  is  composed  of  an
excitation  light  source,  an  interrogation  probe,  a  portable
spectrophotometer  USB  2000  (Ocean  Optics,  USA)  and  a  lap-
top.  Two  solid  state  lasers,  a  diode  emitting  at  406  nm  and  a
doubled-frequency  neodymium:  YAG  at  532  nm,  were  used  as
excitation  light  sources.  The  interrogation  probe  is  a  Y-type
ﬁberoptic  probe,  where  one  tip  is  connected  to  the  spec-
trophotometer  and  the  other  one  to  the  excitation  laser.
Two  optical  ﬁbers  of  600  m  in  diameter  are  positioned  side
by  side.  One  conducts  the  excitation  light  and  the  other  col-
lects  the  re-emitted  light  by  the  tissue.  The  outer  diameter
of  the  interrogation  tip  is  1.6  mm  and  the  total  diameter  of
the  area  that  is  placed  in  contact  with  the  tissue  surface
is  3.2  mm.  The  spectroscopic  data  was  acquired  using  the
software  OOIBase32  (Ocean  Optics,  USA).
All  subjects  were  interviewed  and  the  data  ﬁlled
in  a  standardized  interview  form  containing  information
regarding  the  habits  (including  tobacco  and  alcohol  con-
sumption),  family  history,  etc.  Clinical  examination  was
performed  and  examiner  clinical  impression  was  recorded.
In  patients  with  cancer  (C)  and  PMD,  clinical  characteristics,
including  lesion  dimensions,  color,  and  site  were  evaluated.
In  vivo  ﬂuorescence  spectroscopy  measurements  were  per-
formed  under  both  excitation  wavelengths,  collecting  as
many  points  needed  to  cover  the  whole  lesion  surface,  at
least  one  hour  after  the  last  meal.  In  the  case  of  identiﬁca-
tion  of  superﬁcial  clinical  heterogeneities,  as  leukoplakia  or
erythroplakia,  ﬂuorescence  spectra  were  taken  and  iden-
tiﬁed  to  correlate  with  distinct  clinical  patterns.  Tissue
research  was  not  taken  from  area  of  necrosis,  usually
present  at  the  center  of  ulcerated  lesions.  In  each  chosen
area,  ﬁve  spectroscopic  measurements  under  each  wave-
length  were  taken.  The  patient  evaluation  was  performed  at
the  surgical  theater  at  A.C.  Camargo  Hospital,  after  induc-
tion  of  general  anesthesia,  and  at  outpatient  clinics  at  LELO,
before  the  biopsy  procedure  or  surgical  resection  of  the
lesions.
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A  3  mm  punch  biopsy  was  taken  at  patients  with  cancer
at  the  time  of  surgery.  Biopsy  sites  were  matching  with  spe-
ciﬁc  spectroscopic  measurement  sites,  and  were  performed
according  to  heterogenicity  of  the  lesion  deﬁned  by  the
physician  based  on  clinical  judgment.  Tissue  specimens  were
stored  in  plastic  vials  containing  10%  formalin  solution  for
histology  processing.
In  volunteers  with  normal  mucosa,  and  no  history  of
cancer,  ﬂuorescence  measurements  were  taken  from  the
border  of  the  tongue  (BOT),  dorsum  of  the  tongue  (DOT),
ﬂoor  of  the  mouth  (FOM),  lower  labial  mucosa  (LB),  buccal
mucosa  (BM),  gingiva  or  alveolar  ridge,  hard  palate  and
lip,  with  at  least  5  spectroscopy  measurements  for  each
excitation  wavelength.  From  each  area,  an  exfoliative
cytology  was  performed.
The  spectra  were  analyzed  according  to  the  different
anatomical  sites  and  amended  by  tissue  injury  com-
pared  to  normal  tissue.  The  results  were  correlated  with
the  histopathological  diagnosis.  Different  types  of  com-
putational  processing  were  conducted  to  evaluate  the
discrimination  among  normal  mucosa  (NM),  PMD,  and  cancer
(C).
Initially,  all  spectra  were  analyzed  based  on  classiﬁcation
and  independent  of  anatomical  site.  In  a  second  analysis,
principal  component  analysis  (PCA)  was  performed,  classi-
fying  the  spectra  also  according  to  the  anatomical  site.  PCA
was  applied  using  three  types  of  spectrum  preprocessing:
normalization  by  maximum  intensity,  standardization  and
analysis  of  the  ﬁrst  derivative  and  the  second  derivative.
Classiﬁcation  using  spectral  indices  (SI)  based  on  qualita-
tive  analysis  of  the  spectra  was  also  performed.  The  SI  was
deﬁned  comparing  emission  intensities  at  wavelengths  mod-
iﬁed  in  the  PMD  and  OSCC  groups,  when  compared  to  the  NM.
The  index  used  to  classify  the  spectra  can  be  expressed  by
the  following  equation:
R  =
∫ 643.2
623.1
I  d
∫ 506.6
485.4
I  d
where  I  is  emission  intensity,  in  arbitrary  units,  and    is  the
emission  wavelength.
Finally,  computational  classiﬁers  were  also  used  to
achieve  a  more  robust  system  for  spectra  classiﬁcation.  In
one  analysis,  the  classiﬁers  were  applied  to  the  database
without  any  spectral  normalization  and  a  second  analy-
sis  with  the  spectra  normalized  by  its  maximum  emission.
This  approach  could  lead  to  a  better  comprehension  about
the  role  of  spectrum  intensity  in  the  quality  of  classiﬁca-
tion.  Three  different  classiﬁers  were  used:  Naïve  Bayes,
k-nearest  neighbor  (kNN)  and  a  decision  tree  C4.5  (J48),  all
of  them  implemented  on  open  source  software  WEKA  [44].
All  classiﬁers  were  tested  for  both  excitation  wavelengths
in  the  exact  same  conditions.  Moreover,  the  excess  of  vari-
ables  (wavelengths)  may  contain  unnecessary  and  redundant
information,  which  can  compromise  the  classiﬁer  perfor-
mance.  Thus,  variables  selection  methods  were  applied
prior  to  computational  classiﬁers  in  order  to  keep  only  the
relevant  ones.  The  selection  methods  used  were  ReliefF  and
CFS  (correlation-feature  selection),  both  present  in  WEKA
software.
Fig.  1  Erythroleukoplakia  lesion  in  the  region  of  the  oral
mucosa  (A)  and  histopathological  diagnosis  corresponding  to
moderate  dysplasia  with  hyperkeratosis  (B).
Results
One  hundred  and  ﬁfteen  subjects  over  18  years  old,  both
genders,  smokers  and  nonsmokers  were  investigated  in  this
study.  The  subjects  were  enrolled  in  the  study  as  55  OSCC
patients,  30  patients  with  PMD,  and  30  volunteers  with  nor-
mal  oral  mucosa,  without  history  of  malignancy  in  airway
digestive  tract.  Of  the  total  of  115  subjects,  54  (47%)  were
women  and  61  (53%)  men.  The  mean  age  was  58.59  years  old,
while  among  women  was  54.5  years  and  for  men  was  62.69.
Each  biopsy  was  analyzed  by  a certiﬁed  oral  pathologist
blind  to  the  ﬂuorescence  results,  describing  the  diagnosis
and  histopathological  characteristics  (Figs.  1  and  2).  Five
patients  presented  more  than  one  lesion,  resulting  in  99
interrogated  lesions.  Classiﬁcation  was  based  on  histopatho-
logical  diagnosis  as  gold  standard.  Fluorescence  patterns
were  determined,  identifying  spectroscopic  features  for
each  type  of  mucosa  evaluated.  The  sample  distribution
based  on  the  histopathological  analysis  and  site  location  is
presented  at  Table  1.
Among  85  individuals  with  lesions  in  the  oral  mucosa,  56
were  OSCC  patients  and  underwent  surgery  for  resection  of
the  lesion  with  tridimensional  surgical  margins.  The  most
affected  anatomical  site  was  the  BOT  (25  lesions,  44.5%),
followed  by  the  BM  (11  lesions,  19.5%),  FOM  and  LM,  5
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Fig.  2  Ulcerated  lesion  in  the  region  of  the  lower  alveolar
ridge (A)  and  the  corresponding  histopathological  diagnosis  of
OSCC  well  differentiated  (B).
lesions  each,  and  alveolar  ridge  (retromolar  region)  with
4  lesions.
The  qualitative  comparison  between  the  effectiveness
of  violet  and  green  light  excitation  for  ﬂuorescence  in  the
detection  of  oral  cancer  was  performed.  The  oral  mucosa
showed  distinct  ﬂuorescence  features  in  distinct  interro-
gated  sites.
Variation  at  ﬂuorescence  intensity  was  observed  depend-
ing  on  oral  site,  and  inter-  and  intra-patient  measurements.
Due  to  the  fact  that  these  differences  may  result  from  probe
positioning,  and  pressure,  the  intensity  emission  raw  val-
ues  were  not  used  for  diagnostic.  As  overall  analysis  of  the
ﬂuorescence  spectral  behavior,  the  higher  emission  intensi-
ties  were  present  at  palate  and  alveolar  ridge,  for  406  nm
excitation.  The  tongue  and  the  FOM  are  highly  vascular-
ized  tissues,  and  hemoglobin  is  the  main  biological  absorber
resulting  in  the  low  intensity  of  the  spectra  collected  classi-
ﬁcation  (Figs.  3  and  4).  We  observed  that  the  center  of  the
cancer  lesion  emits  very  low  ﬂuorescence  signal,  while  the
borders  emit  distinct  ﬂuorescence  emissions  depending  on
the  heterogeneity  of  the  lesion  and  site  location.
The  BOT  site  showed  the  major  spectral  differences  in
the  shape  and  intensity  of  the  ﬂuorescence  emission.  This
site  is  a  transition  region  of  dorsal  and  ventral  tongue.  The
dorsum  of  the  tongue  shows  a  unique  mucosa  with  the  pres-
ence  of  large  papillae  and  high  bacteria  colonization  that
produces  porphyrin  compounds,  which  emits  a  high  intensity
red  ﬂuorescence.  Analyzing  the  ﬂuorescence  from  erythro-
plakia  lesions,  a  lower  intensity  is  observed  when  compared
to  the  NM  emission  intensity,  due  to  higher  hemoglobin  con-
tent,  which  is  the  main  endogenous  absorber.  Excitation  at
406  nm  provided  the  spectra  with  best  ﬂuorescence  discrim-
ination  in  all  analysis  performed.  Although,  excitation  at
532  nm  reach  a  deeper  region  in  the  tissue,  the  endoge-
nous  ﬂuorophores  involved  in  OSCC  are  better  excited  at
the  ultraviolet  region  and  the  initial  changes  of  epithelial
tissue  start  at  the  most  superﬁcial  layers.
Spectral  results  from  NM  at  normal  volunteers  and  NM  at
PMD  patients  presented  distinct  patterns.
Initially,  principal  component  analysis  (PCA)  was  per-
formed  to  compare  the  raw  spectra  of  PMD  versus  NM
from  the  PMD  patients  versus  NM  from  volunteers,  with-
out  discrimination  of  the  anatomical  site.  Secondly,  the
comparison  was  performed  of  PMD,  OSCC  and  NM  from  volun-
teers.  No  satisfactory  result  was  achieved  for  406  or  532  nm
excitation,  even  after  pre-processing  data,  as  spectral  nor-
malization  tools.
The  spectral  index  analysis  was  performed  for  spectra
collected  from  normal  volunteer  (NM)  and  normal  con-
tralateral  mucosa  (NC).  Fifty  patients  and  75  sites  were
selected.  However  only  36  cases  presented  contralateral
normal  mucosa  (NC),  for  intrapatient  comparison.  High  vari-
ance  was  observed  for  the  calculated  index  values  of  C  and
NC  oral  mucosa.  The  standard  deviation  for  the  normal  oral
mucosa  is  lower  when  compared  to  the  cancer  at  the  same
Table  1  Distribution  of  lesions  by  anatomic  site  correlated  with  the  histopathological  diagnosis.
Anatomical  site  Total  number  of  lesions  Number  of  lesions  by  histological  diagnosis
Potentially  malignant
disorders
In  situ
carcinoma
Microinvasive
carcinoma
Invasive
carcinoma
Border  of  tongue  39  14  2  0  23
Floor of  the  mouth  11  6  2  0  3
Buccal mucosa  21  10  0  1  10
Labial mucosa  8  3  0  0  5
Gingiva 11  8  0  0  3
Retromolar 4  0  0  1  3
Palate 5  2  1  0  2
86  A.L.N.  Francisco  et  al.
Fig.  3  Comparison  between  normal  mucosa,  potentially
malignant  disorder  and  border  of  lesion  of  OSCC  in  anatomic
site  border  of  tongue,  the  excitation  of  406  nm  (A)  and  532  nm
(B).
site  location.  This  result  is  correlated  to  the  distinct  histol-
ogy  and  clinical  patterns  for  the  oral  carcinoma  that  are
presented.  Despite  of  this,  the  spectral  indexes  analysis
did  not  result  in  clear  distinction  between  the  classiﬁca-
tion  groups  at  a  global  comparison.  In  a  intra-site  analysis
the  NM,  C  and  PMD  groups  were  separated.  However,  due  to
small  sampling,  statistical  analysis  could  not  be  evaluated.
The  classiﬁcation  using  computational  classiﬁers  was  per-
formed  in  the  whole  dataset  (NM,  PMD,  and  C).  In  the
proposed  analysis  with  the  computational  classiﬁers  (P  vs.
NN),  the  computational  k-nearest  neighbor  (kNN),  was  used
followed  by  two  other  algorithms:  the  Bayes  and  J48.  The
missing  values  in  Table  2,  marked  with  (***)  are  algorithms
that  were  time  consuming  and  did  not  show  expressive
results.  The  J48  decision  tree  presented  the  best  result,  both
for  532  nm  and  406  nm  excitations.  For  excitation  at  406  nm,
algorithm  J48  +  CFS  showed  88.5%  of  sensitivity  and  93.8%  of
speciﬁcity,  while  for  excitation  at  532  nm  the  same  method
obtained  87%  of  sensitivity  and  91.2%  of  speciﬁcity  (both
with  normalization  by  the  maximum  intensity  emission)
(Table  2).  Considering  just  PMD  and  NM  group,  the  J48  +  CFS
shows  a  sensitivity  equals  to  92%  and  a  speciﬁcity  of  96.5%.
Fig.  4  Comparison  between  normal  mucosa,  potentially
malignant  disorder  and  border  of  lesion  of  OSCC  in  anatomic
site buccal  mucosa,  the  excitation  of  406  nm  (A)  and  532  nm
(B).
Discussion
Changes  on  tissue  architecture  and  biochemical  composi-
tion  that  occur  during  establishment  and  progression  of
the  pathology  result  in  modiﬁcation  of  the  tissue  ﬂuores-
cence  emission.  The  optical  path  of  the  photons  traveling
in  the  tissue  is  driven  by  these  microscopic  characteris-
tics.  The  collection  geometry  of  the  spectroscopy  system
may  also  play  an  important  role  on  the  ﬁnal  collected  ﬂu-
orescence  spectrum  [24—26].  For  oral  cancer  diagnostics,
excitation  wavelength  presented  as  more  effective  is  in  the
400—450  nm  interval  [25,27].  Our  results  also  showed  that
the  406  nm  excitation  presented  more  tissue  information
concerning  malignant  characteristics,  even  though  532  nm
could  potentially  interrogate  a  deeper  tissue  layer.
The  collected  ﬂuorescence  spectra  differ  depending  on
the  excitation  wavelength,  oral  site,  biochemical  compo-
sition  and  tissue  architecture  [28,29].  Distinct  excitation
wavelengths  present  different  photon  energies,  resulting  in
distinct  light-tissue  interaction,  and  may  excite  different
endogenous  ﬂuorophores  [26,30].
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Table  2  Representation  of  the  mathematical  processing  performed  for  analysis,  with  normalization  by  maximum,  system
ﬂuorescence  spectroscopy  to  discrimination  between  normal  and  abnormal  mucosa.
VE  VI
Sensibility  Speciﬁcity  Accuracy  FP  rate  Sensibility  Speciﬁcity  Accuracy  FP  rate
Bayes  0.513 0.8  0.513  0.200  0.618  0.744  0.618  0.256
J48 0.829 0.888 0.829  0.112  0.887  0.936  0.887  0.064
kNN k  =  3 0.647 0.774 0.647 0.226 0.769 0.869  0.769  0.131
kNN k  =  7 0.641 0.766 0.641 0.234 0.76 0.863 0.760  0.137
kNN k  =  11  0.638  0.762  0.638  0.238  0.768  0.859  0.768  0.141
kNN k  =  15  0.641  0.769  0.641  0.231  0.75  0.845  0.750  0.155
kNN k  =  19  0.636  0.765  0.636  0.235  0.748  0.843  0.748  0.157
Bayes +  ReliefF  (10%)  0.515  0.771  0.515  0.229  ***  ***  ***  ***
J48 +  ReliefF  (10%)  0.834  0.889  0.834  0.111  0.885  0.934  0.885  0.066
Best kNN  +  ReliefF  (10%)  0.63  0.761  0.630  0.239  ***  ***  ***  ***
Bayes +  CFS  0.567  0.819  0.567  0.181  0.626  0.759  0.626  0.241
J48 +  CFS  0.87  0.912  0.870  0.088  0.885  0.938  0.885  0.062
kNN +  CFS  0.672  0.785  0.672  0.215  ***  ***  ***  ***
Native  tissue  ﬂuorescence  originates  from  endoge-
nous  ﬂuorophores,  such  as  collagen,  elastin,  structural
components  of  the  tissue,  and  other  biomolecules.  The  ﬂu-
orescence  associated  with  the  presence  of  aromatic  amino
acids  and  proteins  shows  information  about  the  cellular  and
tissue  structure  [23,30].  In  contrast,  the  concentration  of
derivatives  of  pyroxene,  NADH  and  FAD,  varies  with  the
metabolic  status  of  tissue  [31]  and  their  levels  are  altered
in  the  presence  of  pathological  conditions.  The  ﬂuores-
cence  of  these  molecules  is  dependent  on  its  concentration
and  distribution  as  well  as  physicochemical  properties  of
the  environment.  Because  the  modiﬁcation  of  protein  and
metabolic  conditions  occurs  during  malignant  transforma-
tion,  this  ﬂuorescence  interrogation  is  a  useful  tool  to
differentiate  tumor  from  normal  tissue  [26].
When  considering  the  collection  of  the  emitted  ﬂu-
orescence  at  tissue  surface,  not  only  the  ﬂuorophores
distribution  contributes  for  the  spectral  intensity  and  shape
of  ﬂuorescence  detected,  but  also  the  absorbers  and
scatterers  distributions.  Collagen  is  one  of  the  main  contrib-
utors  for  the  oral  mucosa  ﬂuorescence,  and  the  decreased
emission  is  related  to  the  breakdown  of  the  ﬁber  links,
resulted  from  tumor  cells  invasion.  Neoplasia  progres-
sion  also  involves  angiogenesis,  and  structural  epithelium
changes,  resulting  in  modiﬁcation  of  tissue  absorption  and
scattering  [27,31,32].
According  to  Schwarz  et  al.  [18],  during  carcinogenesis
in  the  oral  cavity,  structural  and  biochemical  changes  in
the  epithelium  and  stroma  may  alter  the  optical  proper-
ties  of  dysplastic  and  cancerous  tissues.  Increased  nuclear
size  and  cytoplasm/nucleus  ratio,  microvascular  changes,
degradation  of  collagen  ﬁbers,  increased  of  hemoglobin,  and
changes  in  mitochondrial  concentration  of  NADH  and  FAD,
leading  to  changes  in  the  optical  scattering,  absorption  and
intrinsic  characteristics  of  tissue  autoﬂuorescence.
The  ﬂuorescence  spectroscopy  using  a  ﬁberoptic  probe
interrogation  provides  the  evaluation  of  a  small  tissue  vol-
ume,  especially  when  considering  the  excitation  wavelength
at  the  violet  spectrum.  Poh  et  al.  [27]  using  wide  ﬁeld  ﬂu-
orescence  imaging  showed  the  effectiveness  of  a  simple
handheld  ﬂuorescence  system  (excitation  at  400—460  nm)
to  delineate  the  full  extent  of  a  tumor  which,  in  turn,  can
be  useful  in  guiding  the  complete  tumor  resection  in  the
operating  room.  Optical  changes,  speciﬁcally  the  loss  of
ﬂuorescence  in  the  mucosa  lesion  and  surrounding  tissues
were  used  to  map  the  ﬁeld  cancerization.  Correlation  of
histopathological  characteristics  and  speciﬁc  genetic  alter-
ations  indicate  that  ﬂuorescence  visualization  is  improved
lesion  delineation  (size)  and  ﬁeld  cancerization  detection
compared  to  clinical  judgment  [16,27,32,33].  The  ﬂuores-
cence  spectra  collected  in  the  same  tissue  show  different
ways  depending  on  the  excitation  used.  This  variation  occurs
because  the  penetration  depth  and  the  excited  ﬂuorophores
in  each  wavelength.  The  excitation  at  532  nm  has  a  greater
penetration  depth  compared  to  excitation  at  406  nm  [25].
Moreover,  the  characteristics  of  the  tissue  in  which  the
endogenous  ﬂuorophores  are  present  have  higher  inﬂuence.
The  hemoglobin,  which  is  present  in  the  vascular  spaces
and  in  the  stromal  layer  absorbs  a  portion  of  the  emit-
ted  ﬂuorescence.  This  ﬁnding  is  particularly  visible  in  the
excitation  at  406  nm.  Epithelial  ﬂuorophores  such  as  NADH
also  play  a  role  in  the  features  of  the  spectra  of  shal-
low  depths  and  stromal  ﬂuorophores,  such  as  collagen,
contribute  to  the  measured  signal  from  deeper  regions
[8,18,19].
Schwarz  et  al.  [34]  suggest  that  short  wavelengths
may  be  more  sensitive  than  the  profound  changes  in  the
uptake  of  optical  scattering  properties,  where  occur  the  ini-
tial  changes  detected  in  epithelium,  such  as  nuclear  size
and  nucleus/cytoplasm  ratio,  and  in  the  stromal  surface
region.  In  non-keratinized  tissue  diagnostic  performance
was  achieved  using  only  optical  spectra  short  and  medium
depths.  The  discrimination  spectra  normal  and  abnormal
sites  is  better  when  used  excitations  smaller  ranges,  which
is  heavily  skewed  to  the  epithelial  layer  and  minimizes  the
effects  of  the  absorption  of  hemoglobin  [19,35].  Our  optical
system  do  not  have  discrimination  of  the  information  from
distinct  tissue  layers,  the  ﬁnal  response  is  the  contribution
of  the  total  volume.  This  result  in  a  less  precise  information
of  each  ﬂuorophore  contribution  to  the  ﬁnal  spectrum,  but
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our  results  showed  that  even  the  superﬁcial  information  can
achieve  satisfactory  diagnostic  performance.
Pavlova  et  al.  [35]  suggest  that  oral  epithelium  can  be
divided  into  three  layers  with  different  optical  properties.
The  oral  epithelium  is  composed  of  a  superﬁcial  layer  of  ker-
atin,  which  varies  in  thickness  depending  upon  the  anatomic
location.  The  main  ﬂuorophore  of  the  surface  epithelium
is  keratin,  in  which  there  is  a  layer  of  non-keratinized
epithelium  and  is  occupied  by  intermediate  and  basal  cells
metabolically  active  and  with  less  dispersion.  The  ﬂuores-
cence  from  the  non-keratinized  epithelium  is  associated
with  metabolic  indicators  NADH  and  FAD,  which  increase  in
samples  of  oral  dysplasia.
The  presence  of  inﬂammation  may  be  an  additional  com-
plicating  factor  for  spectroscopic  diagnosis  of  oral  lesions;
autoﬂuorescence  due  to  reduced  inﬂammation  can  be  dif-
ﬁcult  to  distinguish  from  the  reduced  autoﬂuorescence
due  to  neoplasia.  As  inﬂammation  primarily  affects  the
stroma  while  the  dysplastic  epithelium  changes  occur,  the
depth  sensitive  spectral  data,  particularly  obtained  from
superﬁcial  layers  may  provide  more  useful  information  for
discriminating  benign  lesions  from  malignant  or  dysplastic
lesions  [18].
Erythematous  lesions  have  a  lower  ﬂuorescence  intensity
compared  to  leukoplakic  lesions,  probably  the  largest  pres-
ence  of  hemoglobin.  Leukoplakic  lesions  behave  differently
in  re-emission  of  light  because  they  are  rich  in  keratin,  which
has  a  prominent  role  in  the  phenomena  of  scattering  and
absorption  and  ﬂuorescence  intensity  re-emitted  [36—38].
Erythroplakic  mucous  membranes  were  already  diagnosed
with  a  more  advanced  degree  of  atypia  and  frequently  with
an  in  situ  or  microinvasive  cancer,  these  lesions  produced
more  altered  ﬂuorescence  spectra  compared  to  normal  and
there  was  a  tendency  to  have  lower  re-emission  of  light.
These  results  corroborate  the  study  Ebihara  et  al.  [14].
Pavlova  et  al.  [35],  using  a  Monte  Carlo  model,  found
that  43—66%  of  the  total  light  detected  with  a  depth  selec-
tive  probe,  ranging  from  280  nm  to  420  nm,  originated  from
the  thickness  of  the  non  keratinized  epithelium.  The  iden-
tiﬁcation  of  bacterial  contamination  is  important  because
some  bacteria  produce  porphyrins,  and  this  may  change  the
result  of  the  intrinsic  ﬂuorescence  of  the  tissue.  Leaving  the
place  of  contamination  by  oral  microorganisms  optical  dis-
crimination  has  been  primarily  associated  with  a  decrease
in  the  intensity  of  ﬂuorescence  emitted  in  the  tumor  region
as  compared  to  the  healthy  regions.  This  fact  has  been  cor-
related  with  decreased  crosslinking  of  collagen  ﬁbers  and
matrix  components  [8,36].
Similar  results  have  been  previously  reported  in  other
clinical  studies  on  detection  of  oral  cancer.  de  Veld  et  al.
[42]  observed  that  dysplastic  sites  and  tumors  are  accompa-
nied  by  a  progressive  drop  in  ﬂuorescence  intensity,  whereas
Lane  et  al.  [31]  reported  a  loss  of  signal  in  wide  ﬁeld
ﬂuorescence  images  from  potentially  malignant  and  malig-
nant  oral  lesions  compared  to  normal  mucosa  around  of  the
lesion.  The  reduced  ﬂuorescence  associated  with  neopla-
sia  was  seen  in  a  wide  range  of  excitation  wavelengths  of
330—470  nm  in  the  study  of  Schwarz  et  al.  [34].
Pavlova  et  al.  [26]  studied  the  UV  excitation  from  four  dif-
ferent  locations  in  the  tongue  of  a  single  patient.  The  lesion
diagnosed  with  severe  inﬂammation  showed  a  large  drop  in
both  ﬂuorescence  as  epithelial  and  stroma.  Moreover,  while
the  ﬂuorescence  of  the  stroma  of  normal  tissue  stemmed
from  collagen  ﬁbers,  the  stromal  inﬂamed  ﬂuorescence  orig-
inated  mainly  inﬂammatory  cells.  The  oral  lesion  diagnosed
with  dysplasia  was  characterized  by  increased  thickness  ﬂu-
orescent  epithelial  cells  throughout  the  epithelium  and  a
decrease  in  ﬂuorescence  stromal  surface.
McGee  et  al.  [40]  found  that  discrimination  of  dys-
plastic  lesions  versus  cancer  was  more  successful  when
algorithms  are  designed  for  individual  sites.  Similar  results
were  obtained  in  this  study.  The  combination  of  sites  with
the  same  spectral  properties  (ﬂoor  of  mouth  and  border  of
the  tongue)  produced  a  more  accurate  and  consistent  dis-
crimination  performance  than  algorithms  developed  for  all
sites.
The  similarity  between  the  shapes  of  the  spectra  of
normal  and  cancerous  tissues  signiﬁcantly  reduces  the  reli-
ability  of  this  technique  for  cancer  detection.  Several
methods  have  been  investigated  to  solve  this  problem  by
a  statistical  analysis  of  spectral  data  to  reduce  the  ‘‘noise’’
or  the  employment  of  excitement  in  multiple  lengths.  Mul-
tivariate  analysis  based  on  principal  components  analyses
(PCA)  and  support  vector  machines  have  been  introduced  to
identify  spectral  features  which  can  be  correlated  with  the
tissue  pathology  condition,  but  there  are  various  types  of
mathematical  procedures  that  may  be  performed  for  opti-
mal  discrimination  (classiﬁcation)  of  the  samples  [16].
In  the  evaluation  of  biopsy  specimens,  Fryen  et  al.  [41]
observed  that  autoﬂuorescence  becomes  heterogeneous
in  areas  with  neoplastic  cell  pleomorphism.  The  differ-
ent  degrees  of  keratinization  according  differentiation  of
injuries  cause  more  distinct  viewing  of  the  change,  unlike
normal  epithelium.  Even  small  precancerous  lesions  such  as
dysplasia  and  carcinoma  in  situ  show  different  degrees  of
autoﬂuorescence.
Heintzelman  et  al.  [8]  found  that  the  wavelengths  of
350  nm  excitation,  380  nm  and  400  may  be  suitable  for  oral
cancer  detection.  By  using  the  excitation  wavelengths  of
350  nm  and  400  nm  in  the  oral  cavity,  obtained  a  ﬂuores-
cence  emission  at  472  nm,  with  90%  sensitivity  and  88%
speciﬁcity.  In  validation  tests  of  the  experiment,  the  authors
achieved  100%  sensitivity  and  98%  speciﬁcity,  using  the  same
parameters  of  wavelength.  According  to  the  authors,  the
oral  mucosa  showed  a higher  emission  intensity  of  auto-
ﬂuorescence  (450  nm)  at  a  wavelength  of  380  nm  excitation
relative  to  neoplastic  mucosa.
de  Veld  et  al.  [39]  evaluated  by  ﬂuorescence  spec-
troscopy  97  volunteers  with  normal  oral  mucosa  using
seven  different  wavelengths  of  excitation  in  13  anatom-
ical  locations.  The  intensity  of  autoﬂuorescence  showed
its  maximum  between  500  and  510  nm.  The  lower  ﬂuo-
rescence  intensities  were  observed  at  the  border  of  lip
semimucosa  and  border  of  the  tongue,  and  the  largest  in
palate  and  buccal  mucosa.  The  authors  found  that  there  are
small  spectroscopic  differences  between  different  anatom-
ical  locations.  The  total  intensity  of  ﬂuorescence  cannot
be  used  as  a  reference  to  compare  with  a  database,  since
there  are  different  intensities  of  autoﬂuorescence  in  differ-
ent  anatomical  sites,  and  the  variance  between  patients.
Palmer  et  al.  [43]  observed  that  the  largest  differences
between  normal  and  dysplastic  tissue  were  found  in  the
excitation  wavelength  of  410  nm.  Dysplastic  and  malignant
samples  had  increased  ﬂuorescence  above  600  nm,  when
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compared  with  normal  samples  indicating  that  dysplastic
lesions  exhibit  a  ﬂuorescent  characteristic  which  is  not
present  in  normal  mucosa.  The  method  used  by  the  authors
showed  sensitivity,  speciﬁcity  and  accuracy  of  ﬂuorescence
to  differentiate  histologically  normal  tissue  from  dysplastic
and  neoplastic  90%,  91%  and  91%,  respectively.
The  high  level  of  sensitivity  and  speciﬁcity  obtained  with
a  noninvasive  procedure  demonstrates  the  power  of  ﬂuo-
rescence  spectroscopy  as  a  diagnostic  tool  for  detection  of
carcinoma,  especially  considering  that  the  carcinoma  group
showed  great  variability.  A  diagnostic  technique  with  fast
response  can  provide  important  information  for  the  clini-
cian,  aid  in  the  classiﬁcation  of  the  lesion,  scanning  large
areas,  the  delimitation  of  the  lesion  margin,  and  also  in  the
choice  of  the  biopsy  site  [25].
The  clinical  characteristics  were  observed  in  various  dif-
ferent  behaviors  of  ﬂuorescence  spectra.  The  excitation
under  violet  light  showed  higher  levels  of  sensitivity  and
speciﬁcity  for  discrimination  of  normal  versus  carcinoma
compared  with  excitation  at  532  nm.  The  analysis  result
showed  better  results  with  the  algorithm  J48  of  violet  exci-
tation,  compared  to  532  nm.
Our  results  demonstrate  the  potential  of  diagnostic  ﬂu-
orescence  spectroscopy  in  an  objective  and  non-invasive,
dysplastic  and  cancerous  sites  distinguishing  normal  oral
mucosa.  Furthermore,  these  results  support  the  use  of  a  sys-
tem  for  optical  spectroscopy  depth  susceptible  to  improve
performance  in  diagnosis.
The  ﬂuorescence  spectroscopy  has  signiﬁcant  sensitiv-
ity  and  speciﬁcity  for  diagnosing  neoplastic  tissue,  both  in
excitation  at  406  nm  and  at  532  nm.  Excitation  at  406  nm
was  more  efﬁcient  and  can  be  used  as  an  auxiliary  tool  in
clinical  diagnostic  discrimination  of  mucosa  normal  versus
potentially  malignant  disorder  versus  oral  cancer.
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